[Federal Register Volume 64, Number 2 (Tuesday, January 5, 1999)]
[Notices]
[Page 522]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-105]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The contract proposals and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the contract proposals, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis
Panel Efficacy Studies of Chemopreventive Agents I Animal Models.
Date: January 27, 1999.
Time: 9:30 a.m. to 12:00 p.m.
Agenca: To review and evaluate contract proposals.
Place: 6130 Executive Blvd., 6th Floor, Rockville, MD 20852.
Contact Person: Wilna A. Woods, Deputy Chief, Special Review,
Referral and Research Branch, Division of Extramural Activities,
National Cancer Institute, National Institutes of Health, Rockville,
MD 20852, (301) 496-7903.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: December 29, 1998.
LaVerne Stringfield,
Committee Management Officer, NIH.
[FR Doc. 99-105 Filed 1-4-99; 8:45 am]
BILLING CODE 4140-01-M
